Shir‐Jing Ho

A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)

Philip Choi, Fernando Roncolato, Xavier C. Badoux et al. · Blood · 2015 · 72 citations · Full text

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14

Mark Hertzberg, Maher K. Gandhi, Judith Trotman et al. · Haematologica · 2016 · 55 citations · Full text

Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience

Katharine L. Lewis, Collin K. Chin, Kate Manos et al. · British Journal of Haematology · 2020 · 48 citations · Full text

Platelet function testing in uraemic patients

Shir‐Jing Ho, Rosalie Gemmell, Timothy Brighton · Hematology · 2008 · 44 citations · Full text

Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients

Emmanuel J. Favaloro, Joanne Clifford, Emma Leitinger et al. · Journal of Thrombosis and Haemostasis · 2022 · 29 citations · Full text